Smith Bryan E.
Insider CIK 1748041 · ELDN See Remarks · UROV GC/Urovant Sciences, Inc.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 64,500 | — | $0 | 64,500 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2025-01-10 | 2025-01-13 | 150,500 | — | $0 | 150,500 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2024-11-21 | 2024-11-22 | 474,350 | — | $0 | 474,350 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2024-06-13 | 2024-06-14 | 241,650 | — | $0 | 241,650 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-05-01 | 2023-05-02 | 179,000 | — | $0 | 179,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2023-02-01 | 2023-02-02 | 155,000 | — | $0 | 155,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2022-02-01 | 2022-02-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | A Award deriv | 2021-05-03 | 2021-05-04 | 158,500 | — | $0 | 158,500 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 93,450 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 20,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 3,500 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 9,341 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 115,106 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | F Tax w/h | 2021-01-07 | 2021-01-08 | 4,761 | $16.09 | $76.6K | 124,447 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-05-01 | 2020-05-04 | 77,606 | — | $0 | 127,606 | SEC↗ |
| UROV Urovant Sciences Ltd. | M Exercise deriv | 2020-02-19 | 2020-02-21 | 50,000 | — | $0 | 20,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | J Other | 2020-02-19 | 2020-02-21 | 15,165 | $13.08 | $198.4K | 50,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | F Tax w/h | 2020-02-19 | 2020-02-21 | 34,835 | $13.08 | $455.6K | 65,165 | SEC↗ |
| UROV Urovant Sciences Ltd. | M Exercise | 2020-02-19 | 2020-02-21 | 50,000 | $6.88 | $344.0K | 100,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-01-07 | 2020-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-01-06 | 2019-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2018-10-15 | 2018-10-17 | 3,500 | — | $0 | 3,500 | SEC↗ |